A tool to find and access patient-derived cancer models for research.
Official title: Patient Derived Cancer Model (PDCM) Finder
Funded at European Molecular Biology Laboratory · NIH-10903927 · Data updated 2026-11-12
This study is creating a helpful tool that makes it easier for cancer researchers to find and use different cancer models, like cell lines and organoids, so they can do their work more efficiently and ultimately help improve cancer treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | European Molecular Biology Laboratory NIH-funded |
| Lab location | 1 site (Heidelberg, Germany) |
| Project start | September 10, 2020 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $444,149 |
| NIH project number | 5U24CA253539-05 |
| Project ID | NIH-10903927 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are cancer patients whose tumors can be used to develop patient-derived cancer models.
✕Less likely to help
Patients with cancers that do not have corresponding models or those not involved in research may not benefit from this initiative.
What this research studies
This research focuses on creating a comprehensive tool called the Patient Derived Cancer Model (PDCM) Finder, which will aggregate and harmonize data from various cancer models, including human cancer cell lines and organoid cultures. By making this data findable, accessible, interoperable, and reusable (FAIR), the project aims to simplify the process for researchers to locate and utilize these models in their studies. The initiative also includes community outreach to gather input on user needs and promote the resource effectively. Ultimately, this tool will enhance the ability of researchers to conduct cancer research more efficiently.
Why it matters
Potential benefit: If successful, this research could significantly improve cancer research by providing easier access to diverse cancer models, leading to better treatment strategies.
How similar studies have gone: Other research initiatives have successfully created databases for cancer models, indicating that this approach has potential for success.
Where this research is happening
-
European Molecular Biology Laboratory
Heidelberg, Germany Active
Researchers
- Principal investigator: Parkinson, Helen Elizabeth — European Molecular Biology Laboratory
- Study coordinator: Parkinson, Helen Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.